findmyKOL
Clinical trialNCT05231187CompletedObservational

T2Resistance - Detection of Resistance Related Genes

SponsorT2 BiosystemsEnrollment1,566Resistance Bacterial
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • Zuckerberg San Francisco General Hospital

    San Francisco, California, United States

  • Tampa General Hospital

    Tampa, Florida, United States

  • Ochsner Medical Center

    New Orleans, Louisiana, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • University Health, Truman Medical Center

    Kansas City, Missouri, United States

  • New York University Langone Health

    Brooklyn, New York, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Rhode Island Hospital

    Providence, Rhode Island, United States

  • University of Texas Health Science Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Jan 2022
Primary completion
31 May 2023
Completion
24 Apr 2024
Last update posted
19 Dec 2024
Registered enrollment
1,566
Registry id
NCT05231187

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.